
IASLC/X
Aug 26, 2025, 19:26
HT25: Tokyo Is Where Science Meets Impact – IASLC
The International Association for the Study of Lung Cancer (IASLC) shared a post on X:
“HT25: Tokyo is where science meets impact!
- Molecular and immune drivers of early lung cancer
- Biomarkers and AI diagnostics
- Translational science to clinical care
- Emerging therapies to intercept disease
Join the conversation this November.”
More posts featuring IASLC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 26, 2025, 19:26
Aug 26, 2025, 19:21
Aug 26, 2025, 18:38
Aug 26, 2025, 18:28
Aug 26, 2025, 17:21
Aug 26, 2025, 17:15
Aug 26, 2025, 17:09